These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35045944)

  • 1. Chaperoning shape-shifting tau in disease.
    Ryder BD; Wydorski PM; Hou Z; Joachimiak LA
    Trends Biochem Sci; 2022 Apr; 47(4):301-313. PubMed ID: 35045944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DnaJC7 binds natively folded structural elements in tau to inhibit amyloid formation.
    Hou Z; Wydorski PM; Perez VA; Mendoza-Oliva A; Ryder BD; Mirbaha H; Kashmer O; Joachimiak LA
    Nat Commun; 2021 Sep; 12(1):5338. PubMed ID: 34504072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
    Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
    Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species.
    Nachman E; Wentink AS; Madiona K; Bousset L; Katsinelos T; Allinson K; Kampinga H; McEwan WA; Jahn TR; Melki R; Mogk A; Bukau B; Nussbaum-Krammer C
    J Biol Chem; 2020 Jul; 295(28):9676-9690. PubMed ID: 32467226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau liquid-liquid phase separation: At the crossroads of tau physiology and tauopathy.
    Islam M; Shen F; Regmi D; Petersen K; Karim MRU; Du D
    J Cell Physiol; 2024 Jun; 239(6):e30853. PubMed ID: 35980344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies.
    Brunden KR; Trojanowski JQ; Lee VM
    Nat Rev Drug Discov; 2009 Oct; 8(10):783-93. PubMed ID: 19794442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau Seeding Mouse Models with Patient Brain-Derived Aggregates.
    Robert A; Schöll M; Vogels T
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic Localisation of Tau.
    Hanger DP; Goniotaki D; Noble W
    Adv Exp Med Biol; 2019; 1184():105-112. PubMed ID: 32096032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chaperoning of specific tau structure by immunophilin FKBP12 regulates the neuronal resilience to extracellular stress.
    Jiang L; Chakraborty P; Zhang L; Wong M; Hill SE; Webber CJ; Libera J; Blair LJ; Wolozin B; Zweckstetter M
    Sci Adv; 2023 Feb; 9(5):eadd9789. PubMed ID: 36724228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ordered Assembly of Tau Protein and Neurodegeneration.
    Goedert M; Spillantini MG
    Adv Exp Med Biol; 2019; 1184():3-21. PubMed ID: 32096024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.
    Kumar P; Jha NK; Jha SK; Ramani K; Ambasta RK
    J Alzheimers Dis; 2015; 43(2):341-61. PubMed ID: 25096626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local structural preferences in shaping tau amyloid polymorphism.
    Louros N; Wilkinson M; Tsaka G; Ramakers M; Morelli C; Garcia T; Gallardo R; D'Haeyer S; Goossens V; Audenaert D; Thal DR; Mackenzie IR; Rademakers R; Ranson NA; Radford SE; Rousseau F; Schymkowitz J
    Nat Commun; 2024 Feb; 15(1):1028. PubMed ID: 38310108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.
    Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM
    J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cofactors are essential constituents of stable and seeding-active tau fibrils.
    Fichou Y; Lin Y; Rauch JN; Vigers M; Zeng Z; Srivastava M; Keller TJ; Freed JH; Kosik KS; Han S
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13234-13239. PubMed ID: 30538196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau and Axonal Transport Misregulation in Tauopathies.
    Combs B; Mueller RL; Morfini G; Brady ST; Kanaan NM
    Adv Exp Med Biol; 2019; 1184():81-95. PubMed ID: 32096030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology.
    Zhang S; Zhu Y; Lu J; Liu Z; Lobato AG; Zeng W; Liu J; Qiang J; Zeng S; Zhang Y; Liu C; Liu J; He Z; Zhai RG; Li D
    Elife; 2022 Sep; 11():. PubMed ID: 36048712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.